Wuhan Healthgen Biotechnology Corp.
- Business Type : Manufacturer
- Year Established : 2006
- Main Products : Human Albumin,HSA, Antitrypsin,AAT, BFGF, AFGF,
- Country/Region : China
- Links : China Chemicals, Plastics, and Raw Materials, China Chemical Reagents,
Company Introduction
Healthgen Biotechnology Co., Ltd. is a private Company, which was founded in 2006. We are focusing on developing, manufacturing and marketing a series of environmental friendly and safe products by using the State-of-the-Art platform of OryzExpress, which includes the highly expressing proteins or small peptides in cereal crop endosperm.
Utilizing the OryzExpress platform, Healthgen Biotechnology develops and markets innovative animal-free products for industrial and pharmaceutical use. Its economically advantaged expression capability made it become a breakthrough and innovative protein expression platform.
Gained a number of patented technologies, Healthgen Biotechnology had achievements in developing and commercializing products, such as: OsrHSA (recombinant human serum albumin), OsrAAT(recombinant anti-trypsin), OsraFGF(recombinant acid fibroblast growth factor), OsrbFGF(recombinant basic fibroblast growth factor) and OsrIGF-1(recombinant insulin-like growth factor). These products are widely used for cell culture media, cosmetic additives, industrial reagents, bio-pharmaceuticals and life science research.
Healthgen Biotechnology's Quality Management System has been certified by SGS against the ISO 9001: 2008 requirements, which ensure standardized process as well as qualified products.
Contact Information
- Contact Person : Moki Peng
- Job Title : Senior Sales Manager
- Telephone : 86 - 027 - 59403931
- Fax Number : 86 - 027 - 59413932
- Address : No.666 Gaoxin Avenue, East Lake Development Zone Wuhan Hubei 430075 China
- Fax : 86 - 027 - 59413932
- Website : Visit website
Related Products:Wuhan Healthgen Biotechnology Corp.
No advertising and no spamming please
Wuhan Healthgen Biotechnology Corp. no reviews currently
No reviews currently, you may post the first one.